Livestock producers and international veterinary distributors routinely face a critical operational bottleneck: sourcing stable, high-efficacy antiparasitic solutions without inflating procurement costs. When managing coccidiosis and other parasitic threats in poultry and livestock, the consistency of the active pharmaceutical ingredients is paramount. Partnering with the right China/Custom diclazuril factory can dramatically streamline this process, shifting the dynamic from unpredictable supply chain disruptions to guaranteed quality and tailored formulation engineering.
Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. serves as the definitive solution to this market challenge. Established in 2008, our operations have evolved into a formidable high-tech veterinary drug enterprise that seamlessly integrates R&D, production, sales, and comprehensive service. Stationed in the Xinle City East Industrial Park, our expansive 21,000-square-meter facility is purpose-built to execute specialized pharmaceutical manufacturing. By bridging cutting-edge scientific innovation with robust production capacities, we empower global agricultural partners to mitigate disease outbreaks effectively while relying on securely sourced, custom-tailored veterinary medicines.
True technical superiority in veterinary pharmacology requires infrastructure that significantly surpasses standard manufacturing benchmarks. To operate globally as a leading China/Custom diclazuril factory, strict adherence to modern regulatory frameworks is non-negotiable. In 2022, our manufacturing center successfully passed the rigorous acceptance parameters of the new veterinary drug GMP instituted by the Ministry of Agriculture. This milestone ensures that every batch across our portfolio of over 100 product varieties is synthesized under uncompromising safety and purity controls.
Our facility houses multiple advanced production lines designed specifically for powder, premix, oral solutions, and both solid and liquid mixed feed additives. This deep structural versatility allows us to engineer diclazuril and other essential antiparasitics into the exact administration routes required by specific veterinary protocols.
| Performance Metric | Industry Significance | Our Engineering Standard | Strategic Advantage |
|---|---|---|---|
| Quality & Compliance | Ensures safe animal consumption and strict residue management. | Passed 2022 Ministry of Agriculture Veterinary GMP. | Guarantees uncompromising chemical purity, legal compliance, and reliable dosing efficacy. |
| Manufacturing Scale | Determines the ability to handle large, uninterrupted global supply chains. | 21,000 sqm facility managing 100+ distinct product varieties. | Enables rapid turnaround times and highly scalable custom formulation production. |
| Formulation Versatility | Affects medication bioavailability and practical farm-level administration. | Dedicated lines for oral liquids, premixes, and solid/liquid feed additives. | Delivers optimal ingredient absorption through customized, species-specific delivery mechanisms. |
| Global Accessibility | Facilitates frictionless international procurement and documentation. | Full multilingual infrastructure (Arabic, French, German, Russian, Spanish). | Eliminates communication barriers, accelerating cross-border trade and compliance alignment. |
Strategic veterinary procurement extends far beyond initial unit pricing—it is an investment that fundamentally dictates long-term financial performance. By integrating your supply chain with an authoritative China/Custom diclazuril factory, enterprise-scale farming operations and distributors can significantly lower animal mortality rates and optimize overall feed conversion ratios. Our comprehensive approach to specialized veterinary solutions ensures that biological threats are rapidly neutralized, transforming proactive disease management into measurable economic gain.
Our proactive commitment to research and development—spanning specific antigens, advanced peptides, and customized antiparasitic formulations—means our partners are consistently ahead of the curve. By minimizing treatment failures and lowering the total cost of flock ownership, Shijiazhuang Huajun Animal Pharmaceutical ensures that your clinical outcomes directly drive sustained bottom-line profitability across international markets.
Related products
Top Selling Products
